Assurance Infusion Recalls BUP/HYDROM/SUF Injection Due to Sterility Concerns
Assurance Infusion is recalling 2 syringes of BUP 5MG/HYDROM 15MG/SUF 600MCG/ML injection due to a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls with potential for significant injury (such as lack of sterility assurance in injectable drugs) are classified as Severe.
Plain-English summary
Assurance Infusion is recalling 2 syringes of BUP 5MG/HYDROM 15MG/SUF 600MCG/ML (40ML) INJ in 20 mL syringe. The recall is due to a lack of sterility assurance. The affected product is identified by Lot 12102019@6 with an expiration date of 12/19/2019.
The product was distributed nationwide within the United States. The source text does not specify the number of units distributed or report any illnesses or injuries associated with the product.
Consumers and healthcare providers should stop using the affected product and contact Assurance Infusion at (713) 533-8800 for further instructions.
The recalled product
- Product
- BUP 5MG/ HYDROM 15MG/ SUF 600MCG/ML (40ML) INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Manufacturer
- Assurance Infusion
- Category
- Drug — Injectable
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots: 12102019@6 Exp. 12/19/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 118 recalled by Assurance Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 118 products in this recall →Related recalls
Same manufacturer · Assurance Infusion
See all →- SevereAssurance Infusion Recalls Buprenorphine and Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Buprenorphine and Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- HighHydromorphone Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-06-08
- HighNeostigmine Methylsulfate Injection recalled due to sterility assurance failure
FDA (Drugs) · 2022-07-27
- HighHYDROmorphone HCl Injection Syringes Recalled for Sterility Assurance
FDA (Drugs) · 2022-07-27
- SevereInfusion Options Recalls Mitomycin Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- HighEpinephrine Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-27
- HighInfusion Options Recalls Azacitidine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-21